Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response.
Much is known about the mode of action of drugs and resistance mechanisms under laboratory growth conditions, but research on the bacterial transcriptional response to drug pressure in vivo or efficacious mode of action and transient resistance mechanisms of clinically employed drugs is limited. Acc...
Main Authors: | Jason E Cummings, Richard A Slayden |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5230754?pdf=render |
Similar Items
-
Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis.
by: Jason E Cummings, et al.
Published: (2023-11-01) -
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
by: Sarovich, D, et al.
Published: (2012) -
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
by: Sarovich DS, et al.
Published: (2012-08-01) -
Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
by: Derek S Sarovich, et al.
Published: (2012-01-01) -
Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.
by: Chantratita, N, et al.
Published: (2011)